Date published: 2026-5-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

β-defensin 21 Inhibitors

β-defensin 21 inhibitors are a class of chemical compounds that are specifically designed to modulate the activity of β-defensin 21, a small peptide belonging to the defensin family. β-defensins are part of a larger group of cysteine-rich antimicrobial peptides that play essential roles in various biological processes. Structurally, β-defensin 21 features a characteristic framework stabilized by multiple disulfide bridges between cysteine residues. This structural motif is critical for its ability to interact with cell membranes and other biomolecules. β-defensin 21 inhibitors are often designed to disrupt these structural interactions, either by binding directly to the active site of the peptide or by interfering with its functional domains. The inhibitors typically exhibit specific affinity for β-defensin 21, allowing them to selectively modulate its biochemical functions. They may work by preventing the proper folding of the defensin, blocking key molecular interactions, or altering the peptide's overall stability within cellular environments.

The development and study of β-defensin 21 inhibitors involve detailed exploration of their interaction dynamics at the molecular level. Techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational docking studies are used to understand how these inhibitors bind to β-defensin 21 and affect its conformational states. Additionally, structure-activity relationship (SAR) studies help identify the functional groups on the inhibitors that are critical for binding efficiency and selectivity. Researchers often use these insights to modify chemical structures and improve the binding characteristics of the inhibitors. The understanding of β-defensin 21 inhibition mechanisms provides valuable insight into broader biochemical pathways involving peptide interactions, redox mechanisms, and cysteine-rich protein folding. Furthermore, investigations into β-defensin 21 inhibitors can shed light on the fundamental principles governing peptide-inhibitor binding, which has applications in understanding biological systems and protein engineering.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SB 202190

152121-30-7sc-202334
sc-202334A
sc-202334B
1 mg
5 mg
25 mg
$31.00
$128.00
$454.00
45
(1)

p38 MAPK inhibitor affecting β-defensin 21 through the p38 MAPK pathway. SB203580 inhibits p38 MAPK, disrupting downstream signaling events. By preventing p38-mediated events, it alters the transcriptional regulation of β-defensin 21 in response to extracellular signals.

PI 3-Kγ Inhibitor

648450-29-7sc-203191
5 mg
$76.00
(0)

PI3Kγ inhibitor influencing β-defensin 21 through the PI3K/Akt pathway. AS605240 inhibits PI3Kγ, disrupting downstream signaling events. This interference leads to the downregulation of β-defensin 21 at the transcriptional level in response to extracellular stimuli.